Unknown

Dataset Information

0

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.

ABSTRACT: Inhibitors of the Hedgehog signaling pathway have generated a great deal of interest in the oncology area due to the mounting evidence of their potential to provide promising therapeutic options for patients. Herein, we describe the discovery strategy to overcome the issues inherent in lead structure 1 that resulted in the identification of Smoothened inhibitor 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea (PF-04449913, 26), which has been advanced to human clinical studies.

SUBMITTER: Munchhof MJ 

PROVIDER: S-EPMC4025788 | biostudies-other | 2012 Feb

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Inhibitors of the Hedgehog signaling pathway have generated a great deal of interest in the oncology area due to the mounting evidence of their potential to provide promising therapeutic options for patients. Herein, we describe the discovery strategy to overcome the issues inherent in lead structure 1 that resulted in the identification of Smoothened inhibitor 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea (PF-04449913, 26), which has been advanced to huma  ...[more]

Similar Datasets

Unknown Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1.
| S-EPMC4018057 | biostudies-literature
Unknown Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.
| S-EPMC3109749 | biostudies-literature
Unknown Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
| S-EPMC4018168 | biostudies-literature
Unknown Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.
| S-EPMC4027753 | biostudies-literature
Unknown Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.
| S-EPMC4867477 | biostudies-literature
Unknown Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.
| S-EPMC4007960 | biostudies-literature
Unknown Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor.
| S-EPMC7294707 | biostudies-literature
Unknown UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.
| S-EPMC4148167 | biostudies-literature
Unknown Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
| S-EPMC4007909 | biostudies-other
Unknown Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist.
| S-EPMC4007836 | biostudies-other